Edge
StocktwitsEarnings

Official STOCKTWITS Representative
$AMRX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.18 up 157.14% YoY
• Reported revenue of $796.2M up 9.89% YoY
• Amneal Pharmaceuticals raised its full-year 2026 guidance, now expecting net revenue of $3.10 billion - $3.20 billion, adjusted EBITDA of $750 million - $780 million, and adjusted diluted EPS of $0.96 - $1.06.3
